Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Deloitte
Julphar
Moodys
Citi
Federal Trade Commission
Colorcon
Healthtrust
Teva

Generated: June 22, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: sevelamer carbonate

« Back to Dashboard

sevelamer carbonate

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Genzyme RENVELA sevelamer carbonate FOR SUSPENSION;ORAL 022318 NDA AUTHORIZED GENERIC Winthrop U.S. N 0955-1052-90
Genzyme RENVELA sevelamer carbonate FOR SUSPENSION;ORAL 022318 NDA AUTHORIZED GENERIC Winthrop U.S. N 0955-1054-90
Genzyme RENVELA sevelamer carbonate FOR SUSPENSION;ORAL 022318 NDA Genzyme Corporation N 58468-0131-2
Genzyme RENVELA sevelamer carbonate FOR SUSPENSION;ORAL 022318 NDA Genzyme Corporation N 58468-0131-4
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
US Department of Justice
QuintilesIMS
Chubb
AstraZeneca
Chinese Patent Office
Johnson and Johnson
Cipla
Covington